Pacira Biosciences Inc (PCRX)

R&D to Revenue

15.72%

Quarterly · Period ending:

PCRX logo

PCRX R&D to Revenue

Latest reported15.72%
PCRX Quarterly R&D/Revenue (148.14% → 15.72%)
High-resolution chart · PNG

PCRX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
15.7189%
15.8263%
19.0239%
14.4644%
15.5716%
15.0021%
12.7619%
11.3328%
11.4244%
10.9133%
10.7386%
12.707%
11.1078%
10.6897%
10.18%
11.5874%
15.5138%
13.6748%
9.7453%
9.065%
9.2728%
13.3407%
11.7054%
12.4706%
18.0385%
14.9682%
16.0532%
19.3485%
17.3746%
15.7524%
14.902%
17.8518%
14.5517%
19.2717%
12.6812%
17.4872%
26.5825%
24.0059%
23.4136%
14.2696%
13.4434%
14.4989%
18.9743%
9.4723%
6.1693%
10.2322%
6.2887%
8.5018%
11.059%
14.1945%
14.4079%
25.6331%
28.3356%
50.9623%
31.0431%
41.5626%
15.1653%
16.5812%
62.2726%
109.8079%
120.4895%
90.9397%
167.686%
126.1253%
150.4419%
97.0318%
175.4435%
148.1383%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.